APA

Wirden M., Roquebert B., Derache A., Simon A., Duvivier C., Ghosn J., Dominguez S., Boutonnet V., Ait-Arkoub Z., Katlama C., Calvez V. & Marcelin A. (20060830). Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients. : Antimicrobial agents and chemotherapy.

Chicago

Wirden Marc, Roquebert Bénédicte, Derache Anne, Simon Anne, Duvivier Claudine, Ghosn Jade, Dominguez Stephanie, Boutonnet Véronique, Ait-Arkoub Zaina, Katlama Christine, Calvez Vincent and Marcelin Anne-Genevieve. 20060830. Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients. : Antimicrobial agents and chemotherapy.

Harvard

Wirden M., Roquebert B., Derache A., Simon A., Duvivier C., Ghosn J., Dominguez S., Boutonnet V., Ait-Arkoub Z., Katlama C., Calvez V. and Marcelin A. (20060830). Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients. : Antimicrobial agents and chemotherapy.

MLA

Wirden Marc, Roquebert Bénédicte, Derache Anne, Simon Anne, Duvivier Claudine, Ghosn Jade, Dominguez Stephanie, Boutonnet Véronique, Ait-Arkoub Zaina, Katlama Christine, Calvez Vincent and Marcelin Anne-Genevieve. Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients. : Antimicrobial agents and chemotherapy. 20060830.